Drug Master Files for: tacrolimus
✉ Email this page to a colleague
tacrolimus Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
11137 | I | II | 10/13/1994 | KLINGE PHARMA GMBH | MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES FOR FK506 (TACROLIMUS) OINTMENT FOR CLINICAL SAMPLES IN MUNCHEN, GERMANY |
16833 | A | II | 9/12/2003 | ASTELLAS PHARMA INC | TACROLIMUS (FK506) DRUG SUBSTANCE |
18442 | A | II | 6/21/2005 | BIOCON LTD | TACROLIMUS USP |
18908 | A | II | 10/24/2005 | CONCORD BIOTECH LTD | TACROLIMUS USP |
18985 | A | II | 11/28/2005 | CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD | TACROLIMUS |
19072 | I | II | 12/22/2005 | ZHEJIANG HISUN PHARMACEUTICAL CO LTD | TACROLIMUS (NON-STERILE A PHARMACEUTICAL INGREDIENT) |
19979 | A | II | 11/20/2006 | LEK PHARMACEUTICALS DD | TACROLIMUS |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information